Home/ Compounds/ Kisspeptin

Kisspeptin

Men's Health

Sitting one step upstream of GnRH, kisspeptin is the true master regulator of the male HPG axis. Where exogenous testosterone shuts the axis down and HCG bypasses it, kisspeptin signals the hypothalamus itself — making it the most physiological tool available for preserving endogenous testosterone production, fertility, and sexual response in men.

Male Physiology Applications
HPG Axis SupportTRT CompatibilityErectile FunctionSperm QualityLibidoSexual Brain Processing
Category
Hypothalamic upstream regulator of GnRH
Standard Dose
100-200 mcg
Frequency
1-2x weekly SubQ
Route
SubQ · IV (research)

Key Takeaways

  • Kisspeptin acts one level above GnRH, recruiting the hypothalamus rather than bypassing it like HCG.
  • Targets the KISS1R (GPR54) on GnRH neurons, triggering pulsatile LH and FSH release that remains under normal HPG feedback.
  • Of growing interest in male fertility, testosterone preservation during cycles, and the sexual-brain-processing literature.
  • Pairs naturally with gonadorelin or low-dose CJC-1295 for layered hormonal support.
  • Generally well tolerated in male research populations; affects gonadotropins, so caution in hormone-sensitive conditions.

Male Physiology Mechanism

Kisspeptin's appeal for male physiology lies in the fact that it does not chemically force testosterone production — it asks the body to make it. The result is hormonal support that preserves rather than degrades the endogenous axis.

Upstream of GnRH — the hypothalamic switch

Kisspeptin neurons in the arcuate and anteroventral periventricular nuclei of the hypothalamus express KISS1R (GPR54) on the surface of GnRH neurons. When kisspeptin binds, GnRH is released into the hypophyseal portal system in physiological pulses. This is the same pathway puberty uses, the same pathway dysregulated in hypogonadotropic hypogonadism, and the same pathway suppressed by exogenous testosterone.

TRT compatibility and fertility preservation

Unlike HCG (which directly stimulates Leydig cells and can desensitise the LH receptor over time), kisspeptin re-engages the male brain's own hormonal circuitry. In men on TRT, intermittent kisspeptin dosing has been studied as a means of maintaining testicular volume, intratesticular testosterone, and sperm production — the three things most commonly compromised on long-term exogenous therapy.

Sexual brain processing

Imaging studies show that kisspeptin administration in men activates limbic regions — amygdala, insula, hypothalamus, anterior cingulate — in patterns associated with sexual arousal and emotional processing of erotic stimuli. This effect appears partly independent of testosterone, suggesting a direct central role in male sexual response distinct from its endocrine action.

Male Physiology Applications

Fertility & Sperm Quality

Most-studied application in men. Kisspeptin restores LH/FSH signalling in hypothalamic amenorrhea-equivalent male presentations, supports spermatogenesis on long-term TRT, and is being trialled in fertility clinics as a more physiological alternative to HCG.

TRT Bridge / Off-Cycle Support

Men coming off TRT cycles use kisspeptin to re-engage the dormant HPG axis. Unlike clomiphene or enclomiphene (SERMs acting at the pituitary), kisspeptin works upstream at the hypothalamus, restoring true pulsatile GnRH rather than amplifying a damped signal.

Male Sexual Response

Beyond its endocrine effect, kisspeptin produces measurable changes in sexual brain processing in men. Of practical interest for low libido that persists despite normal testosterone, where the limitation is central not peripheral.

Investigating Suppressed HPG Axis

In diagnostic settings, kisspeptin challenge can distinguish primary hypothalamic dysfunction from pituitary or testicular causes — useful in workup of unexplained low testosterone in younger men.

Dosing Protocol

Goal Route Dose Cycle
Fertility / sperm supportSubQ100–200 mcg1–2× weekly, 8–16 weeks
TRT bridge / restartSubQ200 mcg2× weekly, 6–12 weeks
Sexual response / libidoSubQ100–150 mcg1–2× weekly, ongoing
Diagnostic challengeIV (clinical)0.1–0.3 nmol/kgSingle dose

Pulsatility matters. Kisspeptin is most physiological when dosed in bursts rather than continuous infusion. Twice-weekly subcutaneous dosing approximates the natural KISS1R activation pattern and avoids the receptor downregulation seen with continuous GnRH analogue exposure.

Stacking

Stacks for the male axis are built layer by layer — hypothalamic, pituitary, gonadal — with kisspeptin sitting at the top.

  • Kisspeptin + Gonadorelin: Hypothalamic (kisspeptin) + pituitary (gonadorelin) coverage. Used in TRT-restart protocols where both signals have damped.
  • Kisspeptin + Ipamorelin + CJC-1295: Adds GH-axis support for body composition without antagonising the HPG work. The two axes operate independently at this dose range.
  • Kisspeptin + PT-141: Pairs hormonal sexual function support (kisspeptin) with central MC4R-mediated sexual response (PT-141). Useful where libido and arousal track separately.
  • Kisspeptin alongside TRT: The most common protocol pairing in men's clinics — TRT for steady-state androgen levels, kisspeptin to preserve testicular function and fertility on long-term therapy.
  • Avoid alongside continuous GnRH agonist exposure: Receptor downregulation interferes with the kisspeptin signal. Pulsatile dosing of both is required if combined.

Safety & Regulatory Status

WADA: Not on prohibited list FDA: Investigational Research: Phase II in HSDD, fertility

Generally well tolerated. Used in fertility research safely. Affects gonadotropins — caution in hormone-sensitive conditions.

Kisspeptin is generally well tolerated in male research cohorts. Because it raises LH and FSH, watch for hormonal volatility in men with pre-existing testicular pathology, prostate cancer history (LH-driven testosterone elevation), or pituitary adenoma. Hot flashes, transient headache, and injection site reactions are uncommon but reported. Not appropriate for prepubertal use except in formal endocrine workup.

Clinical Evidence

Kisspeptin vs Related Peptides

Compound Profile Onset Best For
KisspeptinHypothalamic upstreamHours (LH); weeks (clinical)Physiological HPG support, fertility, sexual processing
Gonadorelin (GnRH)Pituitary directMinutes (LH pulse)Pulsatile GnRH replacement
PT-141Central MC4R — sexual response30–60 minAcute arousal / erectile function
IpamorelinGH-axis (separate from HPG)Acute GH pulseBody composition support

Frequently Asked Questions

How is kisspeptin different from HCG for men on TRT?
HCG mimics LH and directly stimulates the Leydig cell. Kisspeptin acts much earlier in the chain, at the hypothalamus, recruiting endogenous GnRH and downstream LH/FSH release. The result is more physiological pulsatile signalling, less receptor desensitisation over time, and preserved FSH (which HCG largely ignores). Many fertility specialists are increasingly treating kisspeptin as the more elegant tool.
Can kisspeptin raise testosterone in men with normal baseline levels?
Mildly, in some users. The dominant use case is not raising testosterone above baseline but preserving or restoring it in suppressed conditions — long-term TRT, post-cycle recovery, hypothalamic hypogonadism. In men with already-normal levels, the more reliable effect is on sexual brain processing and libido rather than total testosterone.
Will kisspeptin affect prostate health?
Indirectly. By raising endogenous LH and therefore testosterone, kisspeptin can elevate downstream androgen signalling. In men with prostate cancer history or active BPH, this warrants the same caution as any HPG-stimulating agent. Routine PSA monitoring is appropriate in older male users.
How long until I notice effects on fertility markers?
Sperm parameters reflect a 70–90 day spermatogenic cycle, so meaningful changes in sperm count and motility require at least 3 months. LH and testosterone respond faster (within weeks). Libido changes are often the earliest subjective signal, typically within 2–4 weeks.
Is kisspeptin compatible with HCG?
Mechanistically yes — they act at different levels — but in practice most clinicians choose one or the other to avoid muddling the response. If both are used, kisspeptin upstream and lower-dose HCG downstream allows finer titration than HCG alone.
Does it cause site reactions or hair loss?
Site reactions are mild and uncommon. Hair loss is theoretically possible via downstream testosterone-to-DHT conversion in genetically susceptible men, the same way endogenous testosterone elevation would. Users with male-pattern baldness already on finasteride or topical 5-AR inhibitors should monitor accordingly.
Clinical Protocol

Start a Kisspeptin Protocol

Alukard provides physician-supervised men's health protocols with GMP-certified Kisspeptin and GMP-certified compounds with comprehensive hormone panels.

Get Protocol

Quick Facts

Molecular weight
1302 Da
Sequence length
10 aa
Half-life
~28 min IV
WADA
Not on prohibited list
FDA
Investigational
Research
Phase II in HSDD, fertility
Research Note

All male physiology applications described on this page are derived from preclinical research, animal models, and limited human case data. None of these uses are FDA-approved indications for Kisspeptin unless otherwise noted. Always work with a physician familiar with peptide therapeutics before beginning a protocol.

Physician-supervised men's health protocols

Start Your Male Physiology Protocol for Kisspeptin

Alukard provides physician-supervised men's health protocols with GMP-certified compounds with comprehensive hormone panels.

HIPAA Compliant · GMP Certified · Physician Supervised